Package 69680-183-30

{"route": ["ORAL"], "spl_id": "ffe5cf41-299a-49e5-a9b8-c9048c4861fa", "openfda": {"upc": ["0369680183305", "0369680185309"], "unii": ["JY0WD0UA60", "3O2T2PJ89D"], "rxcui": ["1599803", "1599805"], "spl_set_id": ["c888a2b2-92c6-46ae-99ea-21de616208b6"], "manufacturer_name": ["Vitruvias Therapeutics, Inc."], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "30 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (69680-183-30)", "package_ndc": "69680-183-30", "marketing_start_date": "20250716"}], "brand_name": "memantine hydrochloride and donepezil hydrochloride", "product_id": "69680-183_ffe5cf41-299a-49e5-a9b8-c9048c4861fa", "dosage_form": "CAPSULE, EXTENDED RELEASE", "pharm_class": ["Cholinesterase Inhibitor [EPC]", "Cholinesterase Inhibitors [MoA]", "N-methyl-D-aspartate Receptor Antagonist [EPC]", "NMDA Receptor Antagonists [MoA]"], "product_ndc": "69680-183", "generic_name": "memantine hydrochloride and donepezil hydrochloride", "labeler_name": "Vitruvias Therapeutics, Inc.", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "memantine hydrochloride and donepezil hydrochloride", "active_ingredients": [{"name": "DONEPEZIL HYDROCHLORIDE", "strength": "10 mg/1"}, {"name": "MEMANTINE HYDROCHLORIDE", "strength": "14 mg/1"}], "application_number": "ANDA216901", "marketing_category": "ANDA", "marketing_start_date": "20250716", "listing_expiration_date": "20261231"}